Published Date : 2025-Mar-03
The Global Transplant Diagnostics Market is expected to grow significantly in 2025, driven by advancements in molecular diagnostics, increased organ transplant procedures, and rising investments in precision medicine. The market is expected to reach a value of $10.48 billion by 2032, at a CAGR of 6.9%, with key players leading innovation in Human Leukocyte Antigen typing, serology, and molecular diagnostics.
In this blog, we explore the top leading companies in the transplant diagnostics market, along with their company overview, website, headquarters, founding year, employee count, and revenue (2024 estimates).
Becton Dickinson and Company (BD), Bio-Rad Laboratories, Illumina, Immucor Transplant Diagnostics, Thermo Fisher Scientific, CareDx, Affymetrix, Abbott Laboratories and BioMérieux.
Below is a list of top leading transplant diagnostics along with company details.
Overview: Becton Dickinson and Company (BD) is a global medical technology leader, specializing in diagnostic solutions, including transplant diagnostics, molecular testing, and HLA typing. The company provides cutting-edge tools for organ transplantation, ensuring compatibility and improving patient outcomes. BD is well known for its advancements in clinical diagnostics, drug delivery systems, and bioscience research tools.
The company's strong global presence and focus on research make it a top player in the transplant diagnostics industry, ensuring safer and more efficient transplant procedures worldwide.
Overview: Bio-Rad Laboratories is a global leader in clinical diagnostics and life science research, offering high-precision solutions for transplant diagnostics. The company specializes in serology and molecular diagnostics for HLA typing, antibody screening, and organ compatibility testing. Bio-Rad’s transplant diagnostics products are widely used in hospitals, research labs, and transplant centers worldwide.
As a top player in the transplant diagnostics market, Bio-Rad’s continued focus on precision diagnostics, automation, and molecular technologies makes it a key partner for healthcare providers and research institutions.
Overview: Illumina is a global leader in next-generation sequencing (NGS) and genomic solutions, playing a critical role in transplant diagnostics, donor-recipient matching, and post-transplant monitoring. With cutting-edge sequencing technology, Illumina helps improve the accuracy and efficiency of HLA typing, immune response profiling, and rejection risk assessment.
With NGS becoming the gold standard in transplant diagnostics, Illumina remains a market leader, providing fast, scalable, and cost-effective solutions for improving transplant success rates.
Overview: Immucor Transplant Diagnostics is a global leader in transfusion and transplantation diagnostics, specializing in HLA typing, antibody screening, and crossmatching tests. The company focuses on ensuring accurate donor-recipient compatibility to improve organ transplant success rates. Immucor’s advanced serological and molecular diagnostic solutions are widely used in hospitals, transplant centers, and research institutions.
With a strong presence in molecular and serological transplant diagnostics, Immucor plays a vital role in enhancing transplant success rates and patient survival.
Overview: Thermo Fisher Scientific is a world leader in biotechnology, clinical diagnostics, and laboratory research, offering advanced transplant diagnostics solutions for HLA typing, donor-recipient compatibility, and post-transplant monitoring. With a strong focus on molecular diagnostics and next-generation sequencing (NGS), Thermo Fisher plays a crucial role in organ transplantation, immunogenetics, and precision medicine.
With a strong market presence and a commitment to innovation, Thermo Fisher remains a key player in the global transplant diagnostics industry, ensuring faster, more accurate, and more accessible transplant compatibility testing.
Overview: CareDx is a leading precision medicine company focused on transplant diagnostics, specializing in non-invasive, post-transplant monitoring solutions. The company is at the forefront of molecular testing, donor-derived cell-free DNA (dd-cfDNA) technology, and AI-driven transplant care. CareDx’s innovative solutions help improve graft survival, detect early signs of organ rejection, and enhance patient outcomes.
As a market leader in post-transplant monitoring, CareDx’s non-invasive solutions help reduce biopsy reliance, improve patient care, and increase long-term organ survival rates.
Overview: Affymetrix now a part of Thermo Fisher Scientific, is a global leader in microarray technology, genotyping, and molecular diagnostics, including transplant diagnostics. The company’s innovative genetic analysis platforms help in HLA typing, donor-recipient matching, and post-transplant monitoring. Affymetrix’s microarray-based solutions provide high-resolution genomic insights, making it a key player in precision medicine for transplantation.
As a key player in transplant diagnostics, Affymetrix (under Thermo Fisher) is advancing genetic and molecular transplant solutions, ensuring more accurate and efficient donor matching and post-transplant care.
Overview: Abbott Laboratories is a multinational healthcare company specializing in clinical diagnostics, molecular testing, and transplant immunology. Abbott plays a crucial role in organ transplant compatibility testing, post-transplant monitoring, and infectious disease screening. With a strong presence in molecular diagnostics, blood screening, and immunoassays, Abbott provides innovative solutions for transplant patients and healthcare providers worldwide.
As a leading force in transplant diagnostics and immunology, Abbott’s cutting-edge diagnostic solutions help optimize organ transplantation success rates, patient safety, and long-term graft survival.
Overview: BioMérieux is a French biotechnology company specializing in clinical diagnostics, microbiology, and infectious disease testing. The company plays a key role in transplant diagnostics by providing cutting-edge molecular testing, immunoassays, and microbiology solutions to assess donor-recipient compatibility, monitor post-transplant infections, and detect early signs of organ rejection.
As a top global player in microbiology and molecular diagnostics, BioMérieux is helping improve transplant success rates by ensuring accurate donor-recipient compatibility and effective infection management.
The transplant diagnostics market is expected to see strong growth across key regions:
The global transplant diagnostics market is on a strong growth trajectory, fueled by technological advancements and increasing organ transplants worldwide. The top 10 companies leading this sector are making significant contributions in molecular diagnostics, sequencing technologies, and precision medicine.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
